AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
PathAI vs Suki AI

Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

PathAI

PathAI

VS
Suki AI

Suki AI

Verdict by Category

AI content generation failed. Refresh the page to try again.
View PathAI View Suki AI

Detailed Comparison

Feature
PathAI
Suki AI
Pricing
EnterprisePathAI operates exclusively on enterprise contracts with hospitals, pathology labs, and biopharma companies — there is no published pricing or self-serve access. Following its acquisition by Roche in May 2026, PathAI's commercial and contract terms are managed through Roche's diagnostics division. Clinical lab engagements use AISight for digital pathology workflow integration and AI algorithm deployment. Biopharma partnerships are structured as research service contracts for clinical trial tissue analysis, biomarker discovery, and companion diagnostic development. Contact PathAI or Roche Diagnostics to explore enterprise and research partnership options.
CustomSuki does not publish pricing on its official website; every path (Suki for Clinicians and Suki for Partners) leads to a "Contact Us" sales conversation rather than a self-serve checkout. Third-party trade coverage and reseller listings throughout 2025-2026 consistently report two tiers: Suki Compose (documentation-only, works with any EHR) at roughly $299 per provider per month, and the full Suki Assistant (deep EHR integration, voice commands, coding, and clinical Q&A) at roughly $399 per provider per month. Enterprise health-system contracts are negotiated separately with volume and specialty-based discounts, and some independent reviews report additional setup fees in the $500-$2,000 range plus annual contract commitments. Exact pricing requires a conversation with Suki's sales team.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
AI-powered digital pathology platform for oncology diagnostics and biopharma R&D — now part of Roche
Ambient clinical AI that turns patient visits into notes, coding, and voice-driven workflows
PathAI

PathAI Pros & Cons

Pros

  • Acquired by Roche (May 2026) — now backed by the world's largest diagnostics company
  • 32.5M+ expert annotations — one of the world's largest pathology AI training datasets
  • 20+ AI algorithms covering oncology, liver disease, and tumor microenvironment analysis
  • AISight is scanner-neutral — works with Leica, Hamamatsu, Philips scanners with FDA clearance
  • CLIA-certified lab services for biopharma clinical trial support
  • Partnerships with BMS, Merck, Moffitt Cancer Center, and University Hospital Zurich
  • First AI pathology company recognized as a leader in CB Insights Digital Pathology market map

Cons

  • Acquired by Roche in May 2026 — future product roadmap and independent operations may change
  • Enterprise and biopharma-focused — not accessible to independent pathologists or small labs
  • No self-serve pricing or trial — all engagements are through enterprise procurement
  • Requires digital pathology infrastructure (scanners, storage, LIS integration)
  • Integration complexity for labs not yet on digital pathology workflows
Suki AI

Suki AI Pros & Cons

Pros

  • Genuine voice-command interface goes beyond passive transcription, letting clinicians drive the EHR by voice
  • Combines documentation, coding, and clinical Q&A in one platform instead of separate point tools
  • Deep, bi-directional integration with the four leading EHRs: Epic, Oracle Health, athenahealth, and MEDITECH
  • Backed by independent KLAS validation of clinical and financial ROI
  • Broad specialty and care-setting coverage, from ambulatory and inpatient to telehealth and home health
  • Suki for Partners lets healthtech companies embed the same ambient AI via APIs and SDKs

Cons

  • No public pricing or free tier; every path on the website leads to a sales demo and a typically annual enterprise contract
  • Reported per-provider pricing (roughly $299-$399/month) runs meaningfully higher than several budget-focused competitors
  • Enterprise-style deployment and contracting can be heavier than solo clinicians or small practices need
  • Learning the voice-command workflow adds a slight learning curve compared with purely passive ambient scribes
  • Doesn't cover adjacent front-office tasks like patient call answering, fax management, or payment collection